News & Updates
Filter by Specialty:

Tirzepatide reduces weight in women with obesity across reproductive stages
Treatment with tirzepatide, compared with placebo, results in significant reductions in body weight, waist circumference, and waist-to-height ratio (WHtR) among women with obesity or overweight and without type 2 diabetes (T2D), regardless of reproductive stage.
Tirzepatide reduces weight in women with obesity across reproductive stages
09 May 2025
Metformin shows knee OA pain-relieving potential
Metformin, a common medication for diabetes, appears to produce a moderate reduction in knee pain and stiffness for overweight or obese individuals with symptomatic knee osteoarthritis (OA), as shown in the results of a randomized clinical trial.
Metformin shows knee OA pain-relieving potential
03 May 2025
Proteomic analysis identifies DKD progression markers in YT2D
A comprehensive analysis of circulating proteins identifies known and novel proteins associated with the progression of diabetic kidney disease (DKD) in Asians with younger-onset type 2 diabetes (YT2D; T2D onset age <40 years).
Proteomic analysis identifies DKD progression markers in YT2D
29 Apr 2025
Progestin-only contraceptives may pose NAFLD risk among women with GDM history
The use of progestin-only contraceptives may put women with a history of gestational diabetes mellitus (GDM) at risk of nonalcoholic fatty liver disease (NAFLD), as shown in a small prospective study.





